Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reirradiation of Locally Recurrent Prostate Cancer with Cyberknife® System or Volumetric Modulated Arc Therapy (VMAT) and IGRT-Clarity®: Outcomes, Toxicities and Dosimetric Evaluation.
Di Franco R, Borzillo V, Scipilliti E, Ametrano G, Serra M, Arrichiello C, Savino F, De Martino F, D'Alesio V, Cammarota F, Crispo A, Pignata S, Rossetti S, Quarto G, Muto P. Di Franco R, et al. Among authors: arrichiello c. Cancers (Basel). 2022 Jun 29;14(13):3187. doi: 10.3390/cancers14133187. Cancers (Basel). 2022. PMID: 35804958 Free PMC article.
SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study.
Serra M, De Martino F, Savino F, D'Alesio V, Arrichiello C, Quarto M, Loffredo F, Di Franco R, Borzillo V, Muto M, Ametrano G, Muto P. Serra M, et al. Among authors: arrichiello c. Life (Basel). 2022 May 10;12(5):711. doi: 10.3390/life12050711. Life (Basel). 2022. PMID: 35629378 Free PMC article.
Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.
Borzillo V, Scipilliti E, Pezzulla D, Serra M, Ametrano G, Quarto G, Perdonà S, Rossetti S, Pignata S, Crispo A, Di Gennaro P, D'Alesio V, Arrichiello C, Buonanno F, Mercogliano S, Russo A, Tufano A, Di Franco R, Muto P. Borzillo V, et al. Among authors: arrichiello c. Front Oncol. 2023 Nov 7;13:1270498. doi: 10.3389/fonc.2023.1270498. eCollection 2023. Front Oncol. 2023. PMID: 38023175 Free PMC article.
The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study.
Leonardi MC, Pepa M, Luraschi R, Vigorito S, Dicuonzo S, Isaksson LJ, La Porta MR, Marino L, Ippolito E, Huscher A, Argenone A, De Rose F, Cucciarelli F, De Santis MC, Rossi F, Prisco A, Guarnaccia R, Tabarelli de Fatis P, Palumbo I, Colangione SP, Mormile M, Ravo V, Fozza A, Aristei C, Orecchia R, Cattani F, Jereczek-Fossa BA; Collaborative Italian Association of Radiotherapy and Clinical Oncology (AIRO) Breast Study Group. Leonardi MC, et al. Radiother Oncol. 2022 Mar;168:113-120. doi: 10.1016/j.radonc.2022.01.004. Epub 2022 Jan 13. Radiother Oncol. 2022. PMID: 35033602
Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.
Franco P, Migliaccio F, Angelini V, Cante D, Sciacero P, Peruzzo Cornetto A, Casanova Borca V, Zeverino M, Torielli P, Arrichiello C, Girelli G, La Porta MR, Tofani S, Numico G, Ricardi U. Franco P, et al. Among authors: arrichiello c. Cancer Invest. 2014 Nov;32(9):458-63. doi: 10.3109/07357907.2014.958495. Epub 2014 Sep 26. Cancer Invest. 2014. PMID: 25259607
Intensity-modulated adjuvant whole breast radiation delivered with static angle tomotherapy (TomoDirect): a prospective case series.
Franco P, Zeverino M, Migliaccio F, Sciacero P, Cante D, Casanova Borca V, Torielli P, Arrichiello C, Girelli G, Numico G, La Porta MR, Tofani S, Ricardi U. Franco P, et al. Among authors: arrichiello c. J Cancer Res Clin Oncol. 2013 Nov;139(11):1927-36. doi: 10.1007/s00432-013-1515-0. Epub 2013 Sep 14. J Cancer Res Clin Oncol. 2013. PMID: 24037488
23 results